Shelley Knight

Shelley Knight has over 15 years of experience in data management roles within the pharmaceutical and clinical research industries. Shelley is currently working as the Executive Director of Data Management at Zenas BioPharma since May 2022. Prior to this, they served as the Executive Director of Data Management at Boston Pharmaceuticals from May 2019 to April 2022. Before that, they held the position of Global Head of Data Management at Catalyst Clinical Research, LLC from March 2019 to May 2019. Shelley also worked as the Senior Director of Clinical Data Management at Epizyme from June 2015 to October 2018. Shelley has also held various leadership positions in data and client services, business development, and clinical data management at companies such as INNO Clinical Outcomes LLC, Ockham, Abraxis BioScience, AAIPharma Services Corp., Comprehensive Neuroscience, Inc, and Duke Clinical Research Institute.

Shelley Knight holds a Bachelor of Arts degree in Communication and Marketing, which they obtained from the University of Arkansas at Little Rock. No information is available regarding the specific start and end year of their education at this institution.